Legato Capital Management LLC Trims Stock Holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Legato Capital Management LLC decreased its position in Integral Ad Science Holding Corp. (NASDAQ:IAS) by 23.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,725 shares of the company’s stock after selling 12,163 shares during the period. Legato Capital Management LLC’s holdings in Integral Ad Science were worth $404,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Stoneridge Investment Partners LLC raised its stake in shares of Integral Ad Science by 139.7% during the 4th quarter. Stoneridge Investment Partners LLC now owns 27,808 shares of the company’s stock valued at $290,000 after buying an additional 16,208 shares during the last quarter. Jennison Associates LLC raised its stake in shares of Integral Ad Science by 3.3% during the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company’s stock valued at $663,000 after buying an additional 2,046 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Integral Ad Science by 47.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock valued at $7,756,000 after buying an additional 231,271 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Integral Ad Science by 12.9% during the 3rd quarter. Franklin Resources Inc. now owns 110,449 shares of the company’s stock valued at $1,191,000 after buying an additional 12,647 shares during the last quarter. Finally, Barclays PLC raised its stake in shares of Integral Ad Science by 207.1% during the 3rd quarter. Barclays PLC now owns 127,733 shares of the company’s stock valued at $1,380,000 after buying an additional 86,133 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Trading Down 1.6 %

IAS stock opened at $10.48 on Friday. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science Holding Corp. has a 12-month low of $7.98 and a 12-month high of $17.53. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of 52.40, a PEG ratio of 1.09 and a beta of 1.46. The business’s 50-day moving average is $10.39 and its 200 day moving average is $10.84.

Integral Ad Science (NASDAQ:IAS) last released its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same period last year, the company posted ($0.09) EPS. The business’s revenue was up 11.0% on a year-over-year basis. On average, sell-side analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Insiders Place Their Bets

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the firm’s stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total value of $132,073.28. Following the transaction, the chief executive officer now directly owns 278,650 shares of the company’s stock, valued at $2,956,476.50. This trade represents a 4.28 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders have sold 19,109 shares of company stock valued at $197,696 in the last ninety days. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Scotiabank began coverage on Integral Ad Science in a research note on Thursday, December 5th. They set a “sector perform” rating and a $10.00 price objective for the company. Oppenheimer dropped their target price on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 13th. Piper Sandler dropped their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 13th. Craig Hallum dropped their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Truist Financial dropped their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $14.80.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.